SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-121372
Filing Date
2021-04-19
Accepted
2021-04-19 16:56:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d89755ddefa14a.htm DEFA14A 19027
2 GRAPHIC g89755na_1.jpg GRAPHIC 186544
3 GRAPHIC g89755na_2.jpg GRAPHIC 104962
  Complete submission text file 0001193125-21-121372.txt   421543
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39041 | Film No.: 21835215
SIC: 2834 Pharmaceutical Preparations